Actelion spinout Idorsia hits goals in insomnia phase 2, sparking stock rise and talk of partnering up for pivotal trial | Fierce Biotech
Jean-Paul Clozel | EY - Global
PharmaBoardroom - Jean-Paul Clozel - CEO, Idorsia
Jean-Paul Clozel
38 Jean Paul Clozel Photos and Premium High Res Pictures - Getty Images
Idorsia - first milestone reached! - Private Wealth - Private Wealth
Jean-Paul und Martine Clozel - Ein Unternehmerpaar der besonderen Art - News - SRF
38 Jean Paul Clozel Photos and Premium High Res Pictures - Getty Images
Clozel's CHF1bn Actelion Spin-Out Idorsia Awaits Janssen Buy-In :: Scrip
J&J Woos Billionaire Doctors Who Don't Need Cash in Actelion Bid - Bloomberg
Der Manager des Jahres heisst Jean-Paul Clozel | Finanz und Wirtschaft
Daridorexant Effective for Insomnia in Phase 3 Trial
Profile: Jean-Paul Clozel | Nature Biotechnology
Jean-Paul Clozel
Jean-Paul Clozel
World Entrepreneur 2008Dr Jean -Paul Clozel with wife Mart… | Flickr
Actelion CEO Becomes a Billionaire With J&J's Bid for Drugmaker - Bloomberg
Actelion wins FDA approval for hypertension drug - San Francisco Business Times
Johnson & Johnson Vice President and Worldwide Chairman Pharmaceuticals Joaquin Duato (L-R), Actelion CEO and founder Jean-Paul Clozel and Johnson & Johnson Chief Scientific Officer Pharmaceuticals Paul Stoffels pose for photographers at ...
Our CEO, Jean-Paul Clozel... - Idorsia Pharmaceuticals Ltd | Facebook
Startup Guide - Jean-Paul and Martine Clozel are... | Facebook
